| Bioactivity | Cav 2.2 blocker 1 (compound 9) is a N-type calcium channel (Cav 2.2) blocker for the treatment of pain, with an IC50 of 1 nM[1]. | ||||||||||||
| Target | IC50: 1 nM (Cav 2.2). | ||||||||||||
| Name | Cav 2.2 blocker 1 | ||||||||||||
| CAS | 1567335-29-8 | ||||||||||||
| Formula | C25H29ClN2O2 | ||||||||||||
| Molar Mass | 424.96 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Wall MJ, et al. Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Cav 2.2) blockers for the treatment of pain. Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3780-3783. |
Cav 2.2 blocker 1
CAS: 1567335-29-8 F: C25H29ClN2O2 W: 424.96
Cav 2.2 blocker 1 (compound 9) is a N-type calcium channel (Cav 2.2)blocker for the treatment of pain, with an IC50 of 1
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.